A detailed history of Saturn V Capital Management LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Saturn V Capital Management LLC holds 215,680 shares of PCVX stock, worth $22.9 Million. This represents 6.15% of its overall portfolio holdings.

Number of Shares
215,680
Previous 185,175 16.47%
Holding current value
$22.9 Million
Previous $12.6 Billion 28.75%
% of portfolio
6.15%
Previous 5.07%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$60.06 - $78.77 $1.83 Million - $2.4 Million
30,505 Added 16.47%
215,680 $16.3 Billion
Q1 2024

May 15, 2024

BUY
$59.79 - $81.05 $11.1 Million - $15 Million
185,175 New
185,175 $12.6 Billion

Others Institutions Holding PCVX

About Vaxcyte, Inc.


  • Ticker PCVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,315,100
  • Market Cap $6.3B
  • Description
  • Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...
More about PCVX
Track This Portfolio

Track Saturn V Capital Management LLC Portfolio

Follow Saturn V Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saturn V Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Saturn V Capital Management LLC with notifications on news.